Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients-Reference-Cited by-同舟云学术

Serum protease-activated receptor (PAR-1) levels as a potential biomarker for diagnosis of inflammation in type 2 diabetic patients

Published:2022-08-16 Issue:5 Volume:30 Page:1843-1851
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Goyal Sanjay,Sood Ankita,Gautam Isha,Pradhan Soumyadip,Mondal Puskar,Singh Gaaminepreet^ORCID,Jaura Ravinder Singh,Singh Thakur Gurjeet,Sibia Raminderpal Singh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-022-01049-0.pdf

Reference55 articles.

1. Antoniak S, Cardenas JC, Buczek LJ et al (2017) Protease-activated receptor 1 contributes to angiotensin II-induced cardiovascular remodeling and inflammation. Cardiology 136(4):258–268. https://doi.org/10.1159/000452269

2. Asokananthan N, Graham PT, Fink J et al (2002) Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 168(7):3577–3585. https://doi.org/10.4049/jimmunol.168.7.3577

3. Austin KM, Covic L, Kuliopulos A (2013) Matrix metalloproteases and PAR1 activation. Blood, J Hematol Am Soc 121(3):431–439

4. Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab 38(3):183–191. https://doi.org/10.1016/j.diabet.2011.11.006

5. Chen H, Smith M, Herz J et al (2021) The role of protease-activated receptor 1 signaling in CD8 T cell effector functions. Iscience 24(11):103387. https://doi.org/10.1016/j.isci.2021.103387

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral infection and host immune response in diabetes;IUBMB Life;2023-12-08

2. The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk;International Journal of Molecular Sciences;2023-10-18